Staff

Ernst J. Schaefer, M.D., Laboratory Director
Senior Scientist and Professor, Medicine and Nutrition
Research focus: nutrition, genetics, aging, gender effects, lipoproteins, and cardiovascular disease risk

Bela Asztalos, Ph.D.
Scientist I and Associate Professor, Medicine
Research focus: HDL and cardiovascular disease risk subspecies, coronary heart disease risk, and nutrition

Stefania Lamon-Fava, M.D., Ph.D.
Scientist I and Associate Professor, Nutrition
Research focus: hormonal replacement, nutrition, lipoproteins, and cardiovascular disease risk

Julian Marsh, M.D.
Scientific Advisor and Professor Emeritus, Medicine
Research focus: lipoprotein metabolism and cholesterol absorption

Mariko Tani, PhD , Postdoctoral Fellow.
Research Focus: the composition and metabolism of high density lipoprotein particles

Hironobu Akao, MD, Postdoctoral Fellow
Research Focus: Plasma lipoproteins, genetics, and heart disease in the elderly

Esther Ooi, PhD , Postdoctoral Fellow
Research Focus: the effects of dietary modification and pharmacologic intervention on human lipoprotein metabolism

Joi Augustin Gleason, M.S., R.D., Senior Research Nutritionist

Margaret Diffenderfer, Ph.D., Senior Research Assistant

Katalin V. Horvath, M.S., Research Assistant

Michael Horan, BS , Graduate Student
Research Focus: the effects of omega 3 fatty acids on cardiovascular risk and mononuclear cell gene expression

Ebony Green, Budget and Administrative Assistant

For contact information, please click on the scientist's webpage or visit the Tufts University online directory athttp://whitepages.tufts.edu/.

Learn More

For?more information about the Lipid Metabolism Laboratory, please visit the USDA, Agricultural Research Service.

Study: Fat hormone can lead to dementia
Dr. Schaefer leads a study showing that a hormone found in body fat may give older women an increased risk of dementia and Alzheimer's.

Study: Pill Can Boost "Good" Cholesterol
A new study by Tufts researchers finds that a drug can help raise HDL, or ?good,? cholesterol levels -- which may usher in a new way to fight heart disease.